Trial Profile
PSMA-PET Registry for Recurrent Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2023
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PREP
- 16 Mar 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 16 Mar 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Mar 2024.
- 01 Sep 2022 Results assessing performance of 18F-DCFPyL PET/CT or PET/MRI with bone scan and CT with or without multiparametric MRI using data from two clinical studies: NCT03535831 and NCT03718260 published in the Radiology